New Delhi, May 31 (ILNS) The Delhi High Court today disposed of a plea, seeking capping of the prices taken by private hospitals from the COVID-19 patients for their treatment.
(Vivek Aggrawal vs UOI and others)
The Division Bench of Justice D N Patel and Justice Jyoti Singh disposed of the petition, giving liberty to the petitioner to file an Interim Application in a writ petition no 3031/2020 pending before the Division Bench of Justice Vipin Sanghi and Justice Jasmeet Singh with similar prayers.
The Court said the practice of filing the writ petitions on a similar matter pending before any other Bench of the concerned Court will bring the multifariousness of the writ petitions.
This present petition is filed as a Public interest Litigation, seeking direction regarding capping the price taken by private hospitals from the patients for their treatment of COVID-19.
The petition submitted that the hospitals are not following the Covid Protocols. The Directorate General of Health Services had observed that hospitals were admitting mild and moderate cases of Covid-19 which were not in line with the prescribed admission protocol.
The petitioner has also submitted that there is a trend that has been observed in the selling of drugs, black-marketing and hoarding of Remdesivir and Tocilizumab that have been reported and with its scarcity, has limited its supply to hospitals.
The drug is not supposed to be supplied to wholesale distributors or medical counters and it cannot be bought over the counter as well. However, some miscreants still find out a way to hoard the stocks of these life-saving drugs.
Despite having so many prayers in his petition, the petitioner has basically focussed on the issue of such a high and unreasonable price taken by the doctors, hospital for the treatment of COVID-19.
As the outbreak of Novel Coronavirus has already rendered many people jobless and so many people are facing unemployment and economic hardships, the treatment of COVID-19 in itself has proved much expensive.
Though the Indian Government has by and large been successful in putting a cap on the prices of RT-PCR Test, Vaccines, etc and control the market process of the same, however, capping the prices of Remdesivir, Tocilizumab and Oxygen Cylinders is currently been ineffective in controlling the market prices. ILNS/RJ